Streetbeat News

Products Services

SRRK

Scholar Rock announced positive topline results from its Phase 3 Sapphire trial of Apitegromab for Spinal Muscular Atrophy, achieving the primary endpoint with significant improvement in motor function. The company plans to submit FDA and European marketing applications in Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:04 am

BCLI

BrainStorm Cell Therapeutics Inc. (NASDAQ:BCLI) will participate in the 2024 Maxim Healthcare Virtual Summit, where CEO Chaim Lebovits will discuss the upcoming Phase 3b clinical trial for NurOwn®, their ALS therapy. This event is a key opportunity to engage with investors and provide insights into the trial.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:04 am

NSPR

InspireMD has received FDA approval for an Investigational Device Exemption application to begin the CGUARDIANS II pivotal study of its CGuard Prime 80cm Carotid Stent System, which will be used during TCAR procedures.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 11:01 am

JPM

NVDA

PFE

QQQ

SPR

SPY

TSLA

U.S. stock futures are set to open lower as traders await key economic data and Fed minutes. The upcoming third-quarter earnings season, starting with JP Morgan, and Middle East tensions are influencing market sentiment. ETFs like SPY and QQQ are also trading lower. Analysts suggest a market consolidation phase, with potential volatility due to geopolitical and economic factors.

Portfolio Pulse from Shanthi Rexaline

October 07, 2024 | 10:41 am

RKLB

Rocket Lab USA has been selected by NASA to conduct a study on retrieving rock samples from Mars and bringing them back to Earth. This marks a significant milestone in space exploration and could enhance Rocket Lab's reputation and business prospects.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:32 am

MULN

Mullen Automotive Inc. (NASDAQ: MULN) forecasts $75 million in revenue over the next six months while cutting spending by $5.5 million through job reductions and program eliminations. The company aims to streamline operations and focus on commercial revenue growth.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:05 am

AMBO

Ambow Education Holding Ltd. (NYSE:AMBO) has signed a $1.3 million licensing agreement with Inspiring Futures Pte. LTD to expand its AI-driven educational tools globally. This deal allows the production and sale of the HybriU AI UniBox internationally, supporting Ambow's mission to enhance education worldwide.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:04 am

HOFT

Hooker Furnishings has partnered with Margaritaville to launch a new line of home furniture, including indoor and outdoor items. This partnership aims to leverage Margaritaville's strong brand recognition to expand in the home furnishings market.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 10:03 am

SSNLF

Samsung Electronics has announced that it is not interested in spinning off its foundry business, despite market speculation. This decision indicates Samsung's commitment to maintaining its integrated business model, which could impact its competitive positioning in the semiconductor industry.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 9:37 am

AZN

AstraZeneca announced that its Phase 3b trial for Airsupra (Albuterol/Budesonide) met the primary endpoint, showing a significant reduction in severe exacerbation risk when used as a rescue medication compared to Albuterol alone.

Portfolio Pulse from Benzinga Newsdesk

October 07, 2024 | 8:55 am